Association of Gestational Cardiovascular Health With Pregnancy Outcomes
- Conditions
- Pregnant Women
- Registration Number
- NCT05776082
- Brief Summary
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 5000
- Maternal age: 20-49 years;
- Natural conception;
- Single pregnancy;
- Plan to have routine prenatal examinations and give birth in the research center;
- Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy;
- Assisted reproduction;
- Multiple pregnancy;
- Fetus has a known deformity or genetic defects;
- Incomplete clinical data.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Neonatal outcomes Through delivery completion, up to 42 weeks Birth weight(in gram), birth height (in centimetre), gestational week (in week) and other neonatal diseases. They are diagnosed by clinicians and the data is gathered from medical records.
Maternal outcomes Through delivery completion, up to 42 weeks Including pregnancy-induced hypertension, preterm delivery, abortion, delivery way and so on. They are diagnosed by clinicians and the data is gathered from medical records.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Women's Hospital School Of Medicine Zhejiang University
🇨🇳Hangzhou, Zhejiang, China